Corat Therapeutics GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2020-06-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19
- First Posted Date
- 2020-12-19
- Last Posted Date
- 2022-05-25
- Lead Sponsor
- Corat Therapeutics Gmbh
- Target Recruit Count
- 45
- Registration Number
- NCT04674566
- Locations
- 🇩🇪
University Hospital Tübingen, Tübingen, Germany
News
No news found